These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2570047)

  • 1. c-erB-2 oncoprotein expression in malignant and nonmalignant breast tissue.
    McCann A; Johnston PA; Dervan PA; Gullick WJ; Carney DN
    Ir J Med Sci; 1989 Jun; 158(6):137-40. PubMed ID: 2570047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-erbB-2 oncoprotein expression in primary human tumors.
    McCann A; Dervan PA; Johnston PA; Gullick WJ; Carney DN
    Cancer; 1990 Jan; 65(1):88-92. PubMed ID: 2403483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
    Wright C; Angus B; Nicholson S; Sainsbury JR; Cairns J; Gullick WJ; Kelly P; Harris AL; Horne CH
    Cancer Res; 1989 Apr; 49(8):2087-90. PubMed ID: 2564806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study.
    Suwanagool P; Parichatikanond P; Maeda S
    Asian Pac J Allergy Immunol; 1993 Dec; 11(2):119-22. PubMed ID: 7915904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical studies on c-erbB-2 oncoprotein expression in paraffin embedded tissues in invasive and non-invasive human breast lesions.
    Pechoux C; Chardonnet Y; Noël P
    Anticancer Res; 1994; 14(3B):1343-60. PubMed ID: 7915095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
    Tervahauta A; Eskelinen M; Syrjänen S; Lipponen P; Pajarinen P; Syrjänen K
    Anticancer Res; 1991; 11(5):1677-81. PubMed ID: 1685075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
    Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
    J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
    Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
    Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-erbB-2 oncoprotein in screen-detected breast carcinoma: an immunohistological study.
    Soomro S; Taylor P; Shepard HM; Feldmann M; Sinnett HD; Shousha S
    Int J Cancer; 1993 Aug; 55(1):63-5. PubMed ID: 8102130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
    Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW
    J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification.
    Venter DJ; Tuzi NL; Kumar S; Gullick WJ
    Lancet; 1987 Jul; 2(8550):69-72. PubMed ID: 2885574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
    J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between c-erb beta-2 oncogene amplification and the expression of its mRNA and protein in human breast carcinomas.
    Bandyopadhyay D; Dani HD; Samant UC; Redkar AA; Mittra I
    Oncology; 1992; 49(1):9-14. PubMed ID: 1347417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-erb B2 (Her2/neu) is neither overexpressed nor amplified in hepatic neoplasms.
    Vlasoff DM; Baschinsky DY; De Young BR; Morrison CD; Nuovo GJ; Frankel WL
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):237-41. PubMed ID: 12373150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladder.
    Lipponen P; Eskelinen M; Syrjänen S; Tervahauta A; Syrjänen K
    Eur Urol; 1991; 20(3):238-42. PubMed ID: 1688050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection by immunohistochemistry of c-erbB2 oncoprotein in breast carcinomas and benign mammary lesions.
    Edorh A; Leroux A; N'sossani B; Parache RM; Rihn B
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):831-40. PubMed ID: 10541479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-erb B-2 oncoprotein in cancer of the larynx in relation to invasion of the cartilagenous framework and prognosis.
    Tantawy A; Youins L; Hamza M
    Eur Arch Otorhinolaryngol; 1999; 256(2):72-7. PubMed ID: 10068894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.